Back to top
more

The Cooper Companies (COO)

(Delayed Data from NSDQ)

$71.73 USD

71.73
2,235,881

+2.07 (2.97%)

Updated Apr 8, 2026 04:00 PM ET

Pre-Market: $73.00 +1.27 (1.77%) 9:20 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.93%
2Buy18.12%
3Hold10.10%
4Sell5.65%
5Strong Sell2.94%
S&P50011.36%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (74 out of 244)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

The Cooper Companies Inc (COO), based in Pleasanton, CA, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision (CVI) and CooperSurgical (CSI). CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company’s products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness. CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. This strategic business unit has pursued a strategy of consolidation by acquiring critical treatment niches in a fragmented market.

Zacks Equity Research

The Cooper Companies (COO) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

The Cooper Companies (COO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Merit Medical (MMSI) Q4 Earnings and Revenues Top Estimates

by Zacks Equity Research

Merit Medical (MMSI) delivered earnings and revenue surprises of +8.90% and +0.80%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Will Medline's Q4 Earnings Validate Its Prime Vendor Growth Strategy?

by Zacks Equity Research

MDLN is set to report first earnings as a public company, with Prime Vendor growth and brand mix in focus ahead of Q4 results.

Zacks Equity Research

BrightSpring to Post Q4 Earnings: What's in Store for the Stock?

by Zacks Equity Research

BTSG is set to report Q4 earnings with strong pharmacy growth, steady provider gains and improving margins.

Zacks Equity Research

DENTSPLY SIRONA to Post Q4 Earnings: What's in Store for the Stock?

by Zacks Equity Research

XRAY gears up for Q4 results amid U.S. weakness, tariff headwinds and a lowered outlook as investors watch for signs of stabilization.

Zacks Equity Research

Solventum to Post Q4 Earnings: What's in Store for the Stock?

by Zacks Equity Research

SOLV readies Q4 results amid solid momentum, tariff headwinds, and M&A focus as investors watch margins and growth trends closely.

Santanu Roy headshot

Beat the Market the Zacks Way: Micron Technology, Cooper Companies, Coeur Mining in Focus

by Santanu Roy

Micron Technology surges 66.8% in 12 weeks as Zacks spotlights standout picks beating a volatile market despite tech selloff.

Zacks Equity Research

COO vs. WST: Which Stock Is the Better Value Option?

by Zacks Equity Research

COO vs. WST: Which Stock Is the Better Value Option?

Zacks Equity Research

BD Merges Biosciences & Diagnostics Business With Waters

by Zacks Equity Research

BDX completes its Biosciences & Diagnostic spin-off and Waters merger, securing $4B in proceeds as it pivots to a pure-play MedTech focus.

Zacks Equity Research

Align Technology (ALGN) Surpasses Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Align Technology (ALGN) delivered earnings and revenue surprises of +10.10% and +1.33%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?